B lymphocyte Tolerance in Health and Autoimmunity
健康和自身免疫中的 B 淋巴细胞耐受性
基本信息
- 批准号:7215734
- 负责人:
- 金额:$ 37.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-07-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibody FormationAntigen-Presenting CellsAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesBiologicalCell LineageCell Surface ReceptorsCell SurvivalCell physiologyCell surfaceCellsCellular biologyComplement Factor BCytokine ReceptorsDefectDevelopmentDiscriminationDiseaseEnsureFamilyGenerationsGenetic ModelsGoalsGrantHealthImmune ToleranceImmune systemKnock-outLupusLymphoidModelingMusMutationMyelogenousPTPN6 genePathway interactionsPeripheralPhenotypePlayProcessPropertyReceptor SignalingRegulationRoleSignal PathwaySignal TransductionT-Independent AntigensT-LymphocyteTNF geneTestingTimeTissuesToll-Like Receptor 1Toll-like receptorsTumor Necrosis Factor ReceptorWorkcytokinehuman PTPN6 proteinin vivopreventreceptorresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): This is a renewal application of an RO1 grant to study tolerance in peripheral B cells. Several lines of evidence, including prior work on this grant, have shown that peripheral B cell tolerance occurs, often by deletion. This tolerance is a barrier to the development of autoimmune disease. However, B cells in the periphery must also be capable of responding to foreign antigens. B lymphocytes are regulated by many signaling pathways that ensure appropriate development, activation and immune tolerance. In this proposal we focus on three pathways that regulate the development of B cell subsets in the peripheral immune system, peripheral B cell tolerance to tissue specific self-antigens, and the T-independent antibody response. Mutations affecting signaling pathways for toll-like receptors, cell surface inhibitory receptors and receptors for the TNF family cytokine BAFF will be used to probe their roles in B cell autonomous biological responses. The first Aim assesses B cell development, B cell tolerance and TI-2 responses in mice deficient in all Tlr signaling. In Aim 2, the effects on peripheral B cell tolerance and the TI-2 response of suppressing or eliminating SHP-1 in B cells will be assessed. Experiments in Aim 3 test the prediction that TACI-deficient B cells have a specific peripheral tolerance defect owing to dysregulated BAFF signaling and attempt to define the B cell autonomous role of TACI in the TI-2 response. The long term goals of these studies are to understand how the self/non-self discrimination is made, what goes wrong in the development of autoimmunity, and to identify ways that these mechanisms may be manipulated to ameliorate or prevent disease.
描述(由申请人提供):这是一份用于研究外周B细胞耐受性的RO 1资助的更新申请。几条证据线,包括先前的工作,这项赠款,已表明,外周B细胞的耐受性发生,往往是通过删除。这种耐受性是自身免疫性疾病发展的障碍。然而,外周中的B细胞也必须能够对外来抗原作出反应。B淋巴细胞受许多信号通路调节,以确保适当的发育、活化和免疫耐受。在这个建议中,我们集中在三个途径,调节外周免疫系统中的B细胞亚群的发展,外周B细胞耐受组织特异性自身抗原,和T-非依赖性抗体反应。影响toll样受体、细胞表面抑制性受体和TNF家族细胞因子BAFF的受体的信号传导途径的突变将用于探测它们在B细胞自主生物应答中的作用。第一个目标评估了所有Tlr信号传导缺陷的小鼠中的B细胞发育、B细胞耐受性和TI-2应答。在目的2中,将评估抑制或消除B细胞中的SHP-1对外周B细胞耐受性和TI-2应答的影响。目标3中的实验测试了TACI缺陷型B细胞由于BAFF信号传导失调而具有特异性外周耐受缺陷的预测,并试图定义TACI在TI-2应答中的B细胞自主作用。这些研究的长期目标是了解自我/非自我的区分是如何进行的,在自身免疫的发展中出现了什么问题,并确定可以操纵这些机制来改善或预防疾病的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID NEMAZEE其他文献
DAVID NEMAZEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID NEMAZEE', 18)}}的其他基金
Role of PLD3 in nucleic acid recognition and brain function
PLD3在核酸识别和脑功能中的作用
- 批准号:
10525053 - 财政年份:2022
- 资助金额:
$ 37.55万 - 项目类别:
Role of PLD3 in nucleic acid recognition and brain function
PLD3在核酸识别和脑功能中的作用
- 批准号:
10388543 - 财政年份:2021
- 资助金额:
$ 37.55万 - 项目类别:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
表达种系恢复的广泛中和艾滋病毒抗体的敲入小鼠
- 批准号:
10190786 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
表达种系恢复的广泛中和艾滋病毒抗体的敲入小鼠
- 批准号:
10436822 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
Functions of novel phospholipase D proteins in nucleic acid sensing
新型磷脂酶 D 蛋白在核酸传感中的功能
- 批准号:
10405523 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
MicroRNA 和免疫耐受靶基因的功能分析
- 批准号:
10159204 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
表达种系恢复的广泛中和艾滋病毒抗体的敲入小鼠
- 批准号:
9973126 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
Functions of novel phospholipase D proteins in nucleic acid sensing
新型磷脂酶 D 蛋白在核酸传感中的功能
- 批准号:
9810386 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
Functions of novel phospholipase D proteins in nucleic acid sensing
新型磷脂酶 D 蛋白在核酸传感中的功能
- 批准号:
10630110 - 财政年份:2019
- 资助金额:
$ 37.55万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 37.55万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 37.55万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 37.55万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 37.55万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 37.55万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 37.55万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 37.55万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 37.55万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 37.55万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 37.55万 - 项目类别:














{{item.name}}会员




